Overall: 0.00 $

Shopping cart is empty

Cilostazol Related Compound C

Cilostazol Related Compound C

Catalogue No.: VE006098
CAS No.: 865792-18-3

Sign up or login to view prices of this product

Name: Cilostazol Related Compound C
Catalogue No. VE006098
CAS No. 865792-18-3
Molecular Formula C31H45N9O2
Molecular Weight 575.75
Status In-stock
IUPAC Name 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butyl]-3,4-dihydro-2(1H)-quinolinone
Appearance White Powder
Description Cilostazol Related Compound C (CAS No: 865792-18-3) or 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butyl]-3,4-dihydro-2(1H)-quinolinone is an impurity of Cilostazol. Cilostazol notably reduces restenosis and target lesion revascularization rates post successful PTCA. Cilostazol is also a platelet aggregation inhibitor that inhibits intimal proliferation post directional coronary atherectomy and so lowers the restenosis rate in humans.
References Chang, Ki Churl. “Cilostazol Inhibits HMGB1 Release in LPS-Activated RAW 264.7 Cells and Increases the Survival of Septic Mice.” Thrombosis Research, vol. 136, no. 2, Aug. 2015, pp. 456–64, https://doi.org/10.1016/j.thromres.2015.06.017. Tsuchikane, Etsuo, et al. “Impact of Cilostazol on Restenosis after Percutaneous Coronary Balloon Angioplasty.” Circulation, vol. 100, no. 1, July 1999, pp. 21–26, https://doi.org/10.1161/01.cir.100.1.21. Park, Seong-Wook, et al. “Comparison of Cilostazol versu

Request for Quotation

Product successfully added to your cart

Question sent successfully

Benefits

Veeprho's Stock

We have synthesized more than 5000 impurities as on date

Cost Effective Scientific Solution

As we produce in grams, our prices are most competitive around the world

Certified Impurity Standards

All VEEPRHO products are supplied with certificates of analysis.

Certification

Certified by ISO, GMP, OHSAS and many more